ES2016467A6 - Un procedimiento para preparar derivados de benzazepina y benzotiazepina. - Google Patents

Un procedimiento para preparar derivados de benzazepina y benzotiazepina.

Info

Publication number
ES2016467A6
ES2016467A6 ES8902132A ES8902132A ES2016467A6 ES 2016467 A6 ES2016467 A6 ES 2016467A6 ES 8902132 A ES8902132 A ES 8902132A ES 8902132 A ES8902132 A ES 8902132A ES 2016467 A6 ES2016467 A6 ES 2016467A6
Authority
ES
Spain
Prior art keywords
benzazepine
image
benzothiazepine derivatives
benzothiazepine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8902132A
Other languages
English (en)
Inventor
David Floyd
John Thomas Hunt
Spender D Kimball
John Krapcho
Jagabandhu Das
George C Rovnyak
Joel Charles Barrosh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of ES2016467A6 publication Critical patent/ES2016467A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

UN PROCEDIMIENTO PARA PREPARAR DERIVADOS DE BENZAZEPINA Y BENZOTIAZEPINA QUE TIENEN LA FOMULA I
ES8902132A 1988-06-20 1989-06-19 Un procedimiento para preparar derivados de benzazepina y benzotiazepina. Expired - Lifetime ES2016467A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20852188A 1988-06-20 1988-06-20
US07/353,806 US4902684A (en) 1988-06-20 1989-05-22 Benzazepine and benzothiazepine derivatives

Publications (1)

Publication Number Publication Date
ES2016467A6 true ES2016467A6 (es) 1990-11-01

Family

ID=26903265

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8902132A Expired - Lifetime ES2016467A6 (es) 1988-06-20 1989-06-19 Un procedimiento para preparar derivados de benzazepina y benzotiazepina.

Country Status (29)

Country Link
US (1) US4902684A (es)
JP (1) JP2793674B2 (es)
KR (1) KR970002633B1 (es)
CN (1) CN1027262C (es)
AT (1) AT398567B (es)
AU (1) AU614399B2 (es)
BE (1) BE1003305A4 (es)
CA (1) CA1336975C (es)
CH (1) CH681723A5 (es)
EG (1) EG19071A (es)
ES (1) ES2016467A6 (es)
FI (1) FI94246C (es)
FR (1) FR2632953B1 (es)
GB (1) GB2231329B (es)
GR (1) GR1002099B (es)
HU (1) HU210929B (es)
IE (1) IE64242B1 (es)
IL (1) IL90515A (es)
IT (1) IT1230884B (es)
LU (1) LU87865A1 (es)
NL (1) NL8920642A (es)
NO (1) NO179449C (es)
NZ (1) NZ229612A (es)
PL (1) PL162313B1 (es)
PT (1) PT90914B (es)
RU (1) RU2090562C1 (es)
SE (1) SE9004060L (es)
WO (1) WO1989012633A1 (es)
YU (1) YU121389A (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008284A (en) * 1989-02-15 1991-04-16 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
US4946840A (en) * 1989-04-06 1990-08-07 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US4963671A (en) * 1989-11-20 1990-10-16 E. R. Squibb & Sons, Inc. Process for resolving chiral intermediates used in making calcium channel blockers
US5112969A (en) * 1990-04-02 1992-05-12 Merrell Dow Pharmaceuticals Inc. Cyano esters and azepinones
IT1240686B (it) * 1990-04-27 1993-12-17 Luso Farmaco Inst Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
IT1244878B (it) * 1990-12-11 1994-09-12 Lusochimica Spa Processo per la preparazione del (+)-cis-3-(acetossi)-5-!2-( dimetilammino)etil!-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin- 4-(5h)-one cloridrato
PT100631B (pt) * 1991-06-28 1999-06-30 Smithkline Beecham Corp Antagonistas biciclicos de fibrinogenio, seu uso e composicoes farmaceuticas que os contem
IT1255545B (it) * 1992-10-23 1995-11-09 Procedimento per la preparazione di diltiazem
CA2098446A1 (en) * 1992-09-30 1994-03-31 Eckard Weber 2,5-dihydro-2,5-dioxo-1h-azepines and 2,5-dihydro-2-oxo-1h-azepines and the use thereof as excitatory amino acid and glycine receptor antagonists
WO1995002405A1 (en) * 1993-07-16 1995-01-26 Merck & Co., Inc. Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
US6174917B1 (en) 1993-09-08 2001-01-16 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
CN1144482A (zh) * 1994-03-24 1997-03-05 默里尔药物公司 降低胆固醇、抗动脉粥样硬化和降低甘油三酯的巯基乙酰胺二硫化物衍生物
US5580867A (en) * 1994-09-09 1996-12-03 Universite De Montreal Myocardial protection during ischemia and reperfusion
PL333920A1 (en) * 1996-12-10 2000-01-31 Abbott Lab 3-pyridyl enantiomers and their application as pain-relieving agents
US6277844B1 (en) 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
US6472533B1 (en) 1999-04-08 2002-10-29 The Texas A & M University System Ligands for chiral catalysis
GB9907895D0 (en) * 1999-04-08 1999-06-02 Texas A & M Univ Sys Novel ligands for chiral catalysis
JP4527405B2 (ja) * 2002-04-19 2010-08-18 アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティ・オブ・アリゾナ 光毒性を調節する方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312691A (en) * 1963-08-23 1967-04-04 Ciba Geigy Corp 2, 3, 4, 5-tetrahydro-1-benzazepin-2-ones
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS59191036A (ja) * 1983-04-14 1984-10-30 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
GB8316032D0 (en) * 1983-06-11 1983-07-13 Tanabe Seiyaku Co Benzothiazepine derivatives
GB2154578A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co Novel 1,5-benzothiazepine derivatives and processes for preparing the same
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
GB2154577A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co 1,5-benzothiazepines
GB2167063A (en) * 1984-11-17 1986-05-21 Tanabe Seiyaku Co 6 or 9-chloro-1, 5-benzothiazepine derivatives
US4748239A (en) * 1985-06-12 1988-05-31 E. R. Squibb & Sons, Inc. Benzazepine derivatives
CA1271747A (en) * 1985-06-12 1990-07-17 David M. Floyd Benzazepines derivatives
US4584131A (en) * 1985-06-20 1986-04-22 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
DE3717561A1 (de) * 1987-05-25 1988-12-08 Thomae Gmbh Dr K Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA1271748C (en) * 1985-12-12 1990-07-17 BENZAZEPINE DERIVATIVES
FR2597097B1 (fr) * 1986-04-15 1988-12-02 Synthelabo Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
ES2038668T3 (es) * 1986-08-20 1993-08-01 Mcneilab, Inc. Vasodilatadores de benzotiazepina dotados de sustitucion aralquilica.
US4729994A (en) * 1986-08-20 1988-03-08 Mcneilab, Inc. Benzothiazepine vasodilators having aralkyl substitution
US4694002A (en) * 1986-08-21 1987-09-15 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
US4752645A (en) * 1986-10-09 1988-06-21 E. R. Squibb & Sons, Inc. Benzazepine derivatives
ZA893392B (en) * 1988-05-24 1990-01-31 Hoffmann La Roche Process for the manufacture of optically active naphthothiazepinones

Also Published As

Publication number Publication date
PT90914B (pt) 1994-12-30
LU87865A1 (de) 1991-12-16
CN1039585A (zh) 1990-02-14
GR890100410A (el) 1990-05-11
FR2632953A1 (fr) 1989-12-22
IE891957L (en) 1989-12-20
KR970002633B1 (en) 1997-03-06
HU894298D0 (en) 1991-01-28
FI900813A0 (fi) 1990-02-19
FI94246B (fi) 1995-04-28
IT8920933A0 (it) 1989-06-20
IL90515A (en) 1994-07-31
RU2090562C1 (ru) 1997-09-20
ATA901089A (de) 1994-05-15
GB2231329B (en) 1992-10-21
CN1027262C (zh) 1995-01-04
BE1003305A4 (fr) 1992-02-25
WO1989012633A1 (en) 1989-12-28
NL8920642A (nl) 1990-06-01
GB2231329A (en) 1990-11-14
FI94246C (fi) 1995-08-10
CH681723A5 (es) 1993-05-14
NO905485D0 (no) 1990-12-19
GB9002587D0 (en) 1990-08-29
PL162313B1 (pl) 1993-09-30
AU3859389A (en) 1990-01-12
NO179449C (no) 1996-10-09
EG19071A (en) 1994-07-30
US4902684A (en) 1990-02-20
IL90515A0 (en) 1990-01-18
SE9004060L (sv) 1992-06-20
GR1002099B (en) 1995-12-28
YU121389A (en) 1991-04-30
IE64242B1 (en) 1995-07-26
HU210929B (en) 1995-09-28
PT90914A (pt) 1989-12-29
HUT59908A (en) 1992-07-28
JPH04502002A (ja) 1992-04-09
KR920700207A (ko) 1992-02-19
NZ229612A (en) 1992-07-28
SE9004060D0 (sv) 1990-12-19
IT1230884B (it) 1991-11-08
AT398567B (de) 1994-12-27
JP2793674B2 (ja) 1998-09-03
AU614399B2 (en) 1991-08-29
CA1336975C (en) 1995-09-12
FR2632953B1 (fr) 1992-05-29
NO905485L (no) 1991-02-19
NO179449B (no) 1996-07-01

Similar Documents

Publication Publication Date Title
ES2016467A6 (es) Un procedimiento para preparar derivados de benzazepina y benzotiazepina.
HU9300447D0 (en) Medical preparative containing conjugate compound of asialo-glyco-protein
TW414158U (en) Construction of structural body
AU6107390A (en) Use of amide complex compounds
HRP931297A2 (en) Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds
CA1271747C (en) BENZAZEPINE DERIVATIVES
AU3421493A (en) Use of spiperone or spiperone derivatives as immunosuppressant agents
GB9124733D0 (en) Derivatives of poly-4-amino-2-carboxy-1-methyl compounds
CA1271748C (en) BENZAZEPINE DERIVATIVES
GB2244055B (en) Resolution of glycidic acid derivatives
IL100302A0 (en) Preparation of 3-isothiazolone compounds
EP0522157A4 (en) Novel use of alkanamidocarboxybetaine
AU5654994A (en) Use of dinaphthalenes compounds as antiproliferative agents
EP0559894A4 (en) Novel use of alkanamidoammonium compound
ES8800916A1 (es) Un procedimiento para preparar acidos beta-lactamo-hidroxamicos sulfatados en o
IN172911B (es)
GB9121205D0 (en) Derivatives of poly-5-amino-3-carboxy-1-methyl compounds
EP0468927A3 (en) Derivatives of carboxymethylcyclopropane
GB2269014B (en) Assay of NADH
CS693488A1 (en) Derivatives of sulphonamides
HU9400358D0 (en) Use of quinoziline derivatives as orexigenics
GB9112273D0 (en) Use of heterocyclic compound
GB9027866D0 (en) Use of heterocyclic compound
GB9017531D0 (en) New derivatives of poly-4-amino-2-carboxy-1-methyl compounds
GB9112309D0 (en) Use of heterocyclic compounds